NBY Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.3203|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-14.86M|
|Gross Profit Margin (Quarterly)||72.37%|
|Profit Margin (Quarterly)||-2776%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM)||Upgrade|
|11/13/2014||Earnings||Q3 2014 NovaBay Pharmaceuticals, Inc. Earnings Results|
|07/31/2014||Earnings||NovaBay Pharmaceuticals Inc Second Quarter Earnings Results|
|05/30/2014||Misc||Annual General Meeting for NovaBay Pharmaceuticals Inc|
|05/01/2014||Earnings||NovaBay Pharmaceuticals Inc First Quarter Earnings Results|
|03/07/2014||Earnings||NovaBay Pharmaceuticals Inc Fourth Quarter Earnings Results|
NBY Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NovaBay Pharmaceuticals is down 46.83% over the last year vs S&P 500 Total Return up 16.79%, ARCA biopharma down 36.01%, and TetraLogic Pharmaceutical down 31.00%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for NBY
Portfolio Strategies Featuring NBY
Did NovaBay Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.novabaypharma.com
- IR Website: http://novabay.com/investors/shareholder-information
- HQ Country: United States
- HQ State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: December 31, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: September 30, 2014
- Last Fiscal Year End: December 31, 2013
- Next Earnings Release: N/A
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
NovaBay Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on addressing the unmet therapeutic needs of the global, topical anti-infective market with its two distinct categories of products, Aganocides and NeutroPhase.
NBY Excel Add-In Codes
- Name: =YCI("NBY","name")
- Description: =YCI("NBY","description")
- Sector: =YCI("NBY","sector")
- Industry: =YCI("NBY","industry")
- Est. Current Fiscal Year End: =YCI("NBY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.